7 results on '"Adrian Benito"'
Search Results
2. Glutamine Modulates Expression and Function of Glucose 6-Phosphate Dehydrogenase via NRF2 in Colon Cancer Cells
- Author
-
Ibrahim H. Polat, Míriam Tarrado-Castellarnau, Adrian Benito, Claudia Hernandez-Carro, Josep Centelles, Silvia Marin, and Marta Cascante
- Subjects
cancer cell metabolism ,glucose-6-phosphate dehydrogenase ,pentose phosphate pathway ,colon cancer ,oxidative stress ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Nucleotide pools need to be constantly replenished in cancer cells to support cell proliferation. The synthesis of nucleotides requires glutamine and 5-phosphoribosyl-1-pyrophosphate produced from ribose-5-phosphate via the oxidative branch of the pentose phosphate pathway (ox-PPP). Both PPP and glutamine also play a key role in maintaining the redox status of cancer cells. Enhanced glutamine metabolism and increased glucose 6-phosphate dehydrogenase (G6PD) expression have been related to a malignant phenotype in tumors. However, the association between G6PD overexpression and glutamine consumption in cancer cell proliferation is still incompletely understood. In this study, we demonstrated that both inhibition of G6PD and glutamine deprivation decrease the proliferation of colon cancer cells and induce cell cycle arrest and apoptosis. Moreover, we unveiled that glutamine deprivation induce an increase of G6PD expression that is mediated through the activation of the nuclear factor (erythroid-derived 2)-like 2 (NRF2). This crosstalk between G6PD and glutamine points out the potential of combined therapies targeting oxidative PPP enzymes and glutamine catabolism to combat colon cancer.
- Published
- 2021
- Full Text
- View/download PDF
3. Oxidative Pentose Phosphate Pathway Enzyme 6-Phosphogluconate Dehydrogenase Plays a Key Role in Breast Cancer Metabolism
- Author
-
Ibrahim H. Polat, Míriam Tarrado-Castellarnau, Rohit Bharat, Jordi Perarnau, Adrian Benito, Roldán Cortés, Philippe Sabatier, and Marta Cascante
- Subjects
breast cancer ,pentose phosphate pathway ,cancer metabolism ,6PGD ,Biology (General) ,QH301-705.5 - Abstract
The pentose phosphate pathway (PPP) plays an essential role in the metabolism of breast cancer cells for the management of oxidative stress and the synthesis of nucleotides. 6-phosphogluconate dehydrogenase (6PGD) is one of the key enzymes of the oxidative branch of PPP and is involved in nucleotide biosynthesis and redox maintenance status. Here, we aimed to analyze the functional importance of 6PGD in a breast cancer cell model. Inhibition of 6PGD in MCF7 reduced cell proliferation and showed a significant decrease in glucose consumption and an increase in glutamine consumption, resulting in an important alteration in the metabolism of these cells. No difference in reactive oxygen species (ROS) production levels was observed after 6PGD inhibition, indicating that 6PGD, in contrast to glucose 6-phosphate dehydrogenase, is not involved in redox balance. We found that 6PGD inhibition also altered the stem cell characteristics and mammosphere formation capabilities of MCF7 cells, opening new avenues to prevent cancer recurrance after surgery or chemotherapy. Moreover, inhibition of 6PGD via chemical inhibitor S3 resulted in an induction of senescence, which, together with the cell cycle arrest and apoptosis induction, might be orchestrated by p53 activation. Therefore, we postulate 6PGD as a novel therapeutic target to treat breast cancer.
- Published
- 2021
- Full Text
- View/download PDF
4. β-Hydroxybutyrate Oxidation Promotes the Accumulation of Immunometabolites in Activated Microglia Cells
- Author
-
Adrian Benito, Nabil Hajji, Kevin O’Neill, Hector C. Keun, and Nelofer Syed
- Subjects
microglia ,β-hydroxybutyrate ,metabolic reprogramming ,stable-isotope tracing ,metabolomics ,Microbiology ,QR1-502 - Abstract
Metabolic regulation of immune cells has arisen as a critical set of processes required for appropriate response to immunological signals. While our knowledge in this area has rapidly expanded in leukocytes, much less is known about the metabolic regulation of brain-resident microglia. In particular, the role of alternative nutrients to glucose remains poorly understood. Here, we use stable-isotope (13C) tracing strategies and metabolomics to characterize the oxidative metabolism of β-hydroxybutyrate (BHB) in human (HMC3) and murine (BV2) microglia cells and the interplay with glucose in resting and LPS-activated BV2 cells. We found that BHB is imported and oxidised in the TCA cycle in both cell lines with a subsequent increase in the cytosolic NADH:NAD+ ratio. In BV2 cells, stimulation with LPS upregulated the glycolytic flux, increased the cytosolic NADH:NAD+ ratio and promoted the accumulation of the glycolytic intermediate dihydroxyacetone phosphate (DHAP). The addition of BHB enhanced LPS-induced accumulation of DHAP and promoted glucose-derived lactate export. BHB also synergistically increased LPS-induced accumulation of succinate and other key immunometabolites, such as α-ketoglutarate and fumarate generated by the TCA cycle. Finally, BHB upregulated the expression of a key pro-inflammatory (M1 polarisation) marker gene, NOS2, in BV2 cells activated with LPS. In conclusion, we identify BHB as a potentially immunomodulatory metabolic substrate for microglia that promotes metabolic reprogramming during pro-inflammatory response.
- Published
- 2020
- Full Text
- View/download PDF
5. Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965
- Author
-
Marta Braga, Maciej Kaliszczak, Laurence Carroll, Zachary T. Schug, Kathrin Heinzmann, Nicoleta Baxan, Adrian Benito, Gabriel N. Valbuena, Stephen Stribbling, Alice Beckley, Gillian Mackay, Francesco Mauri, John Latigo, Chris Barnes, Hector Keun, Eyal Gottlieb, and Eric O. Aboagye
- Subjects
monocarboxylate transporter 1 ,cancer metabolism ,lactate ,glycolysis ,AZD3965 ,diffuse large B-cell lymphoma ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
The monocarboxylate transporter 1 (MCT1) is a key element in tumor cell metabolism and inhibition of MCT1 with AZD3965 is undergoing clinical trials. We aimed to investigate nutrient fluxes associated with MCT1 inhibition by AZD3965 to identify possible biomarkers of drug action. We synthesized an 18F-labeled lactate analogue, [18F]-S-fluorolactate ([18F]-S-FL), that was used alongside [18F]fluorodeoxyglucose ([18F]FDG), and 13C-labeled glucose and lactate, to investigate the modulation of metabolism with AZD3965 in diffuse large B-cell lymphoma models in NOD/SCID mice. Comparative analysis of glucose and lactate-based probes showed a preference for glycolytic metabolism in vitro, whereas in vivo, both glucose and lactate were used as metabolic fuel. While intratumoral L-[1-13C]lactate and [18F]-S-FL were unchanged or lower at early (5 or 30 min) timepoints, these variables were higher compared to vehicle controls at 4 h following treatment with AZD3965, which indicates that inhibition of MCT1-mediated lactate import is reversed over time. Nonetheless, AZD3965 treatment impaired DLBCL tumor growth in mice. This was hypothesized to be a consequence of metabolic strain, as AZD3965 treatment showed a reduction in glycolytic intermediates and inhibition of the TCA cycle likely due to downregulated PDH activity. Glucose ([18F]FDG and D-[13C6]glucose) and lactate-based probes ([18F]-S-FL and L-[1-13C]lactate) can be successfully used as biomarkers for AZD3965 treatment.
- Published
- 2020
- Full Text
- View/download PDF
6. Efecto De Diferentes Concentraciones De Fructosa Sobre La Producción De Celulosa Bacteriana En Cultivo Estático
- Author
-
Ruben Jaramillo, Olga Perna, Adrian Benito Revollo, Carlos Arrieta, and Edgardo Escamilla
- Subjects
celulosa bacteriana ,fructosa ,Gluconacetobacter xylinus IFO ,cultivo estático. ,Agriculture ,Agriculture (General) ,S1-972 ,Animal culture ,SF1-1100 - Abstract
En la síntesis de celulosa bacteriana se han usado diversas fuentes de carbono, distintas configuraciones de biorreactores y estrategias de cultivo. En este estudio se compara la producción de celulosa bacteriana evaluando el efecto de diferentes concentraciones de fructosa en la producción de celulosa bacteriana (CB) por Gluconacetobacter xylinus IFO en un cultivo estático. El estudio se llevó a cabo en biorreactores cilíndricos de 750 ml, con 200 ml de medio que contenían concentraciones iniciales de 1, 5, 10, 15 % p/v de fructosa a pH 5,6. El volumen del inoculo fue el 10% v/v del volumen de medio de cultivo. La síntesis de celulosa se realizó a temperatura ambiente y a distintos tiempos de incubación que iban de 1,5 hasta 28 días, tiempo en el que se determinaron propiedades fisicoquímicas y mecánicas de la celulosa bacteriana, así como también el consumo de fructosa en función del tiempo para las diferentes concentraciones iniciales de fructosa. Los resultados indican que al 10% p/v de fructosa se obtiene el valor mas alto para la síntesis de CB en gramos de celulosa húmeda por litro de medio de cultivo y se obtuvo el máximo grosor con una disminución del volumen remanente de cultivo; además, se observó un consumo de fructosa hasta de un 90% de la concentración inicial. La comprensibilidad fue menor a un mayor grosor de la película de celulosa. El pH del medio se mantuvo en una región óptima para la síntesis de la CB.
- Published
- 2013
- Full Text
- View/download PDF
7. Metabolic network adaptations in cancer as targets for novel therapies.
- Author
-
Marta Cascante, Adrian Benito, Miriam Zanuy, Pedro Vizán, Silvia Marín, and Pedro de atauri
- Subjects
- *
CANCER treatment , *METABOLITES , *ENZYMES , *STABLE isotopes , *PENTOSE phosphate pathway , *CELL transformation - Abstract
Metabolite concentrations and fluxes are the system variables that characterize metabolism. The systematic study of metabolite profiles is known as metabolomics; however, knowledge of the complete set of metabolites may not be enough to predict distinct phenotypes. A complete understanding of metabolic processes requires detailed knowledge of enzyme-controlled intracellular fluxes. These can be estimated through quantitative measurements of metabolites at different times or by analysing the stable isotope patterns obtained after incubation with labelled substrates. We have identified distinct intracellular fluxes associated with metabolic adaptations accompanying cancer. The maintenance of an imbalance between fluxes for the oxidative and non-oxidative PPP (pentose phosphate pathway) has been shown to be critical for angiogenesis and cancer cell survival. Mouse NIH 3T3 cells transformed by different mutated K-ras oncogenes have differential routing of glucose to anaerobic glycolysis, the PPP and the Krebs cycle. These results indicate that knowledge of metabolic fingerprints associated with an altered genetic profile could be exploited in the rational design of new therapies. We conclude that the understanding of the multifactorial nature of metabolic adaptations in cancer may open new ways to develop novel multi-hit antitumoral therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.